CDER’s Drug Integrity Program Gains Formal Role In Compliance Office Reorg

FDA’s nascent Drug Integrity and Security Program gains an enhanced and more formal role with the reorganization and elevation of the Center for Drug Evaluation and Research’s Office of Compliance to “super-office” status.